Search Results - "REICHEN, Jürg"

Refine Results
  1. 1

    Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells by Trebicka, Jonel, Hennenberg, Martin, Odenthal, Margarete, Shir, Khanwali, Klein, Sabine, Granzow, Michaela, Vogt, Annabelle, Dienes, Hans-Peter, Lammert, Frank, Reichen, Jürg, Heller, Jörg, Sauerbruch, Tilman

    Published in Journal of hepatology (01-10-2010)
    “…Background & Aims Activation of hepatic stellate cells (HSC) and transdifferentiation to myofibroblasts following liver injury is the main culprit for hepatic…”
    Get full text
    Journal Article
  2. 2

    Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years by Torgerson, Paul R, Schweiger, Alexander, Deplazes, Peter, Pohar, Maja, Reichen, Jürg, Ammann, Rudolf W, Tarr, Philip E, Halkik, Nerman, Müllhaupt, Beat

    Published in Journal of hepatology (01-07-2008)
    “…Background/Aims Alveolar echinococcosis (AE) is a serious liver disease. The aim of this study was to explore the long-term prognosis of AE patients, the…”
    Get full text
    Journal Article
  3. 3

    Peginterferon Alfa-2a in Patients with Chronic Hepatitis C by Zeuzem, Stefan, Feinman, S. Victor, Rasenack, Jens, Heathcote, E. Jenny, Lai, Ming-Yang, Gane, Edward, O'Grady, John, Reichen, Jürg, Diago, Moises, Lin, Amy, Hoffman, Joseph, Brunda, Michael J

    Published in The New England journal of medicine (07-12-2000)
    “…Interferon is an essential component of the treatment of chronic hepatitis C virus (HCV) infection. However, treatment with interferon alone is generally…”
    Get full text
    Journal Article
  4. 4

    Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction by GREMION, Christel, GRABSCHEID, Benno, WÖLK, Benno, MORADPOUR, Darius, REICHEN, Jürg, PICHLER, Werner, CERNY, Andreas

    Published in Journal of Virology (01-02-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5

    The future treatment of portal hypertension by Reichen, Jürg, MD, Lebrec, Didier, MD

    “…Increased understanding of the hyperdynamic circulation syndrome has resulted in novel therapeutic approaches, some of which have already reached clinical…”
    Get full text
    Journal Article
  6. 6

    Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: cross-sectional study by Russmann, Stefan, Dowlatshahi, Emmilia A, Printzen, Gert, Habicht, Susanne, Reichen, Jürg, Zimmermann, Heinz

    Published in BMC gastroenterology (05-02-2007)
    “…The epidemiology of liver disease in patients admitted to emergency rooms is largely unknown. The current study aimed to measure the prevalence of viral…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhibition of 11β‐hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis by Ackermann, Daniel, Vogt, Bruno, Escher, Geneviève, Dick, Bernhard, Reichen, Jürg, Frey, Brigitte M., Frey, Felix J.

    Published in Hepatology (Baltimore, Md.) (01-09-1999)
    “…Renal sodium retention and potassium loss occur early, in many instances in the preascitic state of cirrhosis, an observation that cannot be fully explained by…”
    Get full text
    Journal Article
  9. 9

    Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria by Krähenbühl, S, Fischer, S, Talos, C, Reichen, J

    Published in Hepatology (Baltimore, Md.) (01-12-1994)
    “…The effect of ursodeoxycholate and tauroursodeoxycholate on the toxicity of lipophilic bile acids (chenodeoxycholate and lithocholate) on the function of the…”
    Get more information
    Journal Article
  10. 10

    Differentiation between naproxen, naproxen–protein conjugates, and naproxen–lysine in plasma via micellar electrokinetic capillary chromatography—a new approach in the bioanalysis of drug targeting preparations by Albrecht, Christiane, Reichen, Jurg, Visser, Jan, Meijer, Dirk K. F, Thormann, Wolfgang

    Published in Clinical chemistry (Baltimore, Md.) (01-11-1997)
    “…Pharmacotherapy through the targeting of drugs is a promising new approach that requires adequate analytical methods capable of differentiating between the…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats by Gottardi, Andrea De, Shaw, Sidney, Sagesser, Hans, Reichen, Jurg

    Published in Journal of hepatology (01-11-2000)
    “…Background/Aim: Endothelin-1 plays an important role in the regulation of portal hypertension; endothelin antagonists have been extensively studied in portal…”
    Get full text
    Journal Article
  12. 12

    The Role of the Sinusoidal Endothelium in Liver Function by Reichen, Jurg

    Published in Physiology (Bethesda, Md.) (01-06-1999)
    “…Jürg Reichen J. Reichen is Professor of Medicine in the Department of Clinical Pharmacology of the University of Berne, Murtenstrasse 35, 3010 Berne,…”
    Get full text
    Journal Article
  13. 13

    Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance by Steiger, U, Cotting, J, Reichen, J

    Published in Clinical pharmacology and therapeutics (01-03-1990)
    “…We prospectively studied the effect of albendazole on microsomal reserve and on first-pass activation to albendazole sulfoxide in patients with hydatid…”
    Get more information
    Journal Article
  14. 14
  15. 15

    The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions by Fattinger, Karin, Funk, Christoph, Pantze, Michael, Weber, Cornelia, Reichen, Jürg, Stieger, Bruno, Meier, Peter J.

    Published in Clinical pharmacology and therapeutics (01-04-2001)
    “…Background During clinical trials bosentan, the first orally active endothelin receptor antagonist, caused asymptomatic transaminase elevations in some…”
    Get full text
    Journal Article
  16. 16

    Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis by Bihl, Florian, Emmenegger, Urban, Reichen, Jürg, Neftel, Klaus A., Zimmermann, Arthur, Cerny, Andreas

    Published in Journal of hepatology (01-06-2006)
    “…Macrophage activating syndrome (MAS) is a rare hematological disorder associated with uncontrolled systemic T-cell activation. Persistent fever, fatigue and…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20